These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21116120)

  • 21. Lysophosphatidic acid receptor-2 (LPA
    Takahashi K; Minami K; Otagaki S; Ishimoto K; Fukushima K; Fukushima N; Honoki K; Tsujiuchi T
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2698-2703. PubMed ID: 30093116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LPA
    Minami K; Ueda N; Ishimoto K; Tsujiuchi T
    Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lysophosphatidic acid receptor-5 negatively regulates cell motile and invasive activities of human sarcoma cell lines.
    Dong Y; Hirane M; Araki M; Fukushima N; Honoki K; Tsujiuchi T
    Mol Cell Biochem; 2014 Aug; 393(1-2):17-22. PubMed ID: 24676544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No Mutations of Lysophosphatidic Acid Receptor Genes in Lung Adenocarcinomas Induced by N-Nitrosobis(2-hydroxypropyl)amine in Rats.
    Wakabayashi N; Tsujino M; Tajiri M; Taki M; Koshino A; Ikeda H; Fukushima N; Tsujiuchi T
    J Toxicol Pathol; 2010 Mar; 23(1):63-6. PubMed ID: 22272013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterologous expression of G protein-coupled receptors in U-2 OS osteosarcoma cells.
    Ames R; Nuthulaganti P; Fornwald J; Shabon U; van-der-Keyl H; Elshourbagy N
    Recept Channels; 2004; 10(3-4):117-24. PubMed ID: 15512846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and epigenetic alterations of lysophosphatidic Acid receptor genes in rodent tumors by experimental models.
    Tsujiuchi T; Okabe K; Fukushima N
    J Toxicol Pathol; 2011 Sep; 24(3):143-8. PubMed ID: 22272054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the pathologic study on chromosome genes in osteosarcoma].
    Zhao B; Yang GH
    Zhonghua Bing Li Xue Za Zhi; 1994 Feb; 23(1):54-5. PubMed ID: 8044864
    [No Abstract]   [Full Text] [Related]  

  • 28. Enhancement of Drug Resistance by Lysophosphatidic Acid Receptor-3 in Mouse Mammary Tumor FM3A Cells.
    Fukui R; Kato K; Okabe K; Kitayoshi M; Tanabe E; Fukushima N; Tsujiuchi T
    J Toxicol Pathol; 2012 Sep; 25(3):225-8. PubMed ID: 22988342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone cancer: Is the osteosarcoma genome targetable?
    Savage SA; Mirabello L
    Nat Rev Endocrinol; 2017 Sep; 13(9):506-508. PubMed ID: 28776583
    [No Abstract]   [Full Text] [Related]  

  • 30. Polymorphisms of genes related to metotrexate response and toxicity in high-grade osteosarcoma.
    Serra M; Hattinger CM
    Expert Opin Drug Metab Toxicol; 2017 Jan; 13(1):123. PubMed ID: 27852114
    [No Abstract]   [Full Text] [Related]  

  • 31. Mitochondrial DNA depletion may also have a role in pathogenesis of osteosarcoma.
    Kurt B; Gulcan-Kurt Y; Cayci T; Akgul EO
    Int J Exp Pathol; 2013 Oct; 94(5):352. PubMed ID: 24020408
    [No Abstract]   [Full Text] [Related]  

  • 32. A prognostic model based on the integrin genes for osteosarcoma.
    Zhang J; Cheng Z; Chang X; Wang S
    Asian J Surg; 2023 Dec; 46(12):5609-5611. PubMed ID: 37591750
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer stem cells: seeds of growth in osteosarcoma.
    Gillette J; Nielsen-Preiss S
    Cancer Biol Ther; 2009 Mar; 8(6):553-4. PubMed ID: 19411864
    [No Abstract]   [Full Text] [Related]  

  • 34. An evolutionarily conserved mechanism that amplifies the effect of deleterious mutations in osteosarcoma.
    Jiang Y; Ge F; Sun G; Wang H
    Mol Genet Genomics; 2022 Mar; 297(2):373-385. PubMed ID: 35061070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Authors' reply.
    Yu M; Zou Q
    Int J Exp Pathol; 2013 Oct; 94(5):353. PubMed ID: 24020409
    [No Abstract]   [Full Text] [Related]  

  • 36. Osteosarcoma in siblings. Report of two cases.
    Miller CW; McLaughlin RE
    J Bone Joint Surg Am; 1977 Mar; 59(2):261-2. PubMed ID: 265305
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioinformatics analysis of key pathways and genes in osteosarcoma development.
    Yang Z; Zeng K; Shen Y; Yang X; Sun J; Zhu G
    Panminerva Med; 2023 Sep; 65(3):401-402. PubMed ID: 31670495
    [No Abstract]   [Full Text] [Related]  

  • 38. Single-cell RNA sequencing identifies G-protein coupled receptor 87 as a basal cell marker expressed in distal honeycomb cysts in idiopathic pulmonary fibrosis.
    Heinzelmann K; Hu Q; Hu Y; Dobrinskikh E; Ansari M; Melo-Narváez MC; Ulke HM; Leavitt C; Mirita C; Trudeau T; Saal ML; Rice P; Gao B; Janssen WJ; Yang IV; Schiller HB; Vladar EK; Lehmann M; Königshoff M
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 35604813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effective and Large-scale synthesis of 16:0 Lysophosphatidic Acid.
    East JE; Macdonald TL
    Synth Commun; 2012 Dec; 42(24):3614-3618. PubMed ID: 23264701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments.
    Qi Y; Wang Y; Yuan J; Xu Y; Pan H
    Lipids Health Dis; 2024 Jun; 23(1):204. PubMed ID: 38943207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.